Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Epizyme Inc (NASDAQ:EPZM)

16.50
Delayed Data
As of Sep 25
 -0.45 / -2.65%
Today’s Change
8.38
Today|||52-Week Range
20.00
+36.36%
Year-to-Date

Today’s Trading

Previous close16.95
Today’s open17.00
Day’s range16.40 - 17.10
Volume563,170
Average volume (3 months)789,999
Market cap$1.1B
Dividend yield--
Data as of 09/25/2017

Growth & Valuation

Earnings growth (last year)+41.87%
Earnings growth (this year)--
Earnings growth (next 5 years)--
Revenue growth (last year)+212.77%
P/E ratioNM
Price/Sales86.33
Price/Book4.88

Competitors

 Today’s
change
Today’s
% change
NDRMNeuroderm Ltd-0.02-0.06%
SGMOSangamo Therapeutics...-0.25-1.82%
RTRXRetrophin Inc+0.09+0.39%
FPRXFive Prime Therapeut...+0.49+1.39%
Data as of 09/25/2017

Financials

Next reporting dateOctober 24, 2017
EPS forecast (this quarter)-$0.65
Annual revenue (last year)$8.0M
Annual profit (last year)-$110.2M
Net profit margin-1,376.45%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Robert B. Bazemore
Chief Operating Officer
Matthew E. Ros
Corporate headquarters
Cambridge, Massachusetts

Forecasts